GH logo

Guardant Health (GH)

Profile

Full Name

Guardant Health, Inc.

Ticker Symbol

GH

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 4, 2018

Indexes

Not included

Website

http://guardanthealth.com

Employees

1999

Key Details

Price

$48.30(+1.88%)

Market cap

$5.96B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$739.02M(+31.04% YoY)

Annual EPS

-$3.56(+16.82% YoY)

PE ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$48.30
GH price is $48.30

30-Day Relative Volume

0.76
GH 30-day relative volume is 0.76

Price Performance

Price Most recent change

+1.88%
GH price was up +1.88% on Apr 25, 2025

Price YTD change

+58.1%
GH price is up +58.1% since January 1st

Price 1-year change

+181.47%
GH price is up +181.47% year-on-year

Price 3-year change

-30.76%
GH price is down -30.76% over the past 3 years

Price Range

Price All-time high

$181.07
GH price is currently -73.33% below its historical high of $181.07

Price 3-year low

$15.81
GH price is currently +205.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.96B
GH market capitalization is $5.96 billion

Market cap 3-year change

-16.16%
GH market capitalization is down -16.16% over the past 3 years

Market cap All-time high

$17.95B
GH market capitalization is currently -66.79% below its historical high of $17.95 billion

Market cap sector rank

90.06%
GH market capitalization is higher than 90.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.26%
GH shares outstanding is up +1.26% year-on-year

Shares Outstanding 3-Year Change

+21.1%
GH shares outstanding is up +21.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.34
GH beta is 1.34

200-day SMA

$34.09
GH price is currently +41.69% above its 200-day simple moving average

50-day SMA

$43.67
GH price is currently +10.61% above its 50-day simple moving average

RSI

60.90
GH 14-day relative strength index is 60.90

Volume

0.76
GH 30-day relative volume is 0.76

ATR

$2.65
GH average true range is $2.65

10-day Historical Volatility

51.61%
GH 10-day historical volatility is 51.61%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$739.02M
GH annual revenue is $739.02 million

Revenue Analysts estimate

$857.30M
GH annual revenue is currently -13.80% lower than the consensus analysts' forecast

Revenue 1-year change

+31.04%
GH annual revenue is up +31.04% year-on-year

Revenue Sector rank

77.7%
GH annual revenue is higher than 77.7% of companies in Healthcare sector

EPS

EPS

-$3.56
GH annual earnings per share is -$3.56

EPS Analysts estimate

-$2.15
GH annual earnings per share is currently +65.51% higher than the consensus analysts' forecast

EPS 1-year change

+16.82%
GH annual earnings per share is up +16.82% year-on-year

EPS Sector rank

25.38%
GH annual earnings per share is higher than 25.38% of companies in Healthcare sector

Profit

Gross profit

$449.22M
GH annual gross profit is $449.22 million

Gross margin

60.79%
GH annual gross profit margin is 60.79%

Operating profit

-$443.59M
GH annual operating income is -$443.59 million

Operating margin

-60.03%
GH annual operating profit margin is -60.03%

Net income

-$436.37M
GH annual net profit is -$436.37 million

Net margin

-59.05%
GH annual net profit margin is -59.05%

Expenses

Total expenses

$1.18B
GH annual total expenses is $1.18 billion

Operating expenses

$892.81M
GH annual total operating expenses is $892.81 million

Cost of goods sold

$289.80M
GH annual cost of goods sold is $289.80 million

Selling, general & administrative expenses

$545.06M
GH annual SGA is $545.06 million

Depreciation and amortization

$42.39M
GH annual depreciation & amortization is $42.39 million

Interest expense

$2.58M
GH annual interest expense is $2.58 million

Income tax

$1.28M
GH annual income tax is $1.28 million

EBIT & EBITDA

EBIT

-$432.51M
GH annual earnings before interest & taxes is -$432.51 million

EBITDA

-$390.12M
GH annual EBITDA is -$390.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.49B
GH annual total assets is $1.49 billion

Non current assets

$430.50M
GH annual long term assets is $430.50 million

Current assets

$1.06B
GH annual total current assets is $1.06 billion

Cash and cash equivalents

$525.54M
GH annual cash & cash equivalents is $525.54 million

Accounts receivable

$106.85M
GH annual accounts receivable is $106.85 million

Inventory

$71.08M
GH annual inventory is $71.08 million

Liabilities

Total liabilities

$1.63B
GH annual total liabilities is $1.63 billion

Long term liabilities

$1.40B
GH annual total long term liabilities is $1.40 billion

Current liabilities

$225.58M
GH annual total current liabilities is $225.58 million

Accounts payable

$38.55M
GH annual accounts payable is $38.55 million

Debt

Total debt

$1.34B
GH annual total debt is $1.34 billion

Total debt 1-year change

-1.31%
GH annual total debt is down -1.31% year-on-year

Long term debt

$1.31B
GH annual long term debt is $1.31 billion

Short term debt

$29.21M
GH annual short term debt is $29.21 million

Equity & Capital

Shareholders equity

-$139.65M
GH annual stockholders equity is -$139.65 million

Book value

-$139.65M
GH annual book value is -$139.65 million

Retained earnings

-$2.58B
GH annual retained earnings is -$2.58 billion

Working capital

$829.53M
GH annual working capital is $829.53 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$239.86M
GH annual cash flow from operations is -$239.86 million

Cash from operations 1-year change

+26.19%
GH annual cash flow from operations is up +26.19% year-on-year

Cash from investing

-$261.31M
GH annual cash flow from investing activities is -$261.31 million

Cash from investing 1-year change

-131.1%
GH annual cash flow from investing activities is down -131.1% year-on-year

Cash from financing

-$996.00K
GH annual cash flow from financing activities is -$996.00 thousand

Cash from financing 1-year change

-100.21%
GH annual cash flow from financing activities is down -100.21% year-on-year

CAPEX

CAPEX

$35.09M
GH annual capital expenditures is $35.09 million

CAPEX 1-year change

+71.26%
GH annual capital expenditures is up +71.26% year-on-year

Free Cash Flow

Free cash flow

-$274.94M
GH annual free cash flow is -$274.94 million

Free cash flow 1-year change

+20.41%
GH annual free cash flow is up +20.41% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.79%
GH annual gross profit margin is 60.79%

Operating margin

-60.03%
GH annual operating profit margin is -60.03%

Net margin

-59.05%
GH annual net profit margin is -59.05%

ROA & ROE

ROA

-26.67%
GH annual return on assets is -26.67%

ROE

-4584.47%
GH annual return on equity is -4584.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GH price to earnings ratio value is unknown

PE ratio Sector rank

-
GH price to earnings ratio is unknown

PB Ratio

PB ratio

-42.69
GH price to book ratio is -42.69

PB ratio Sector rank

0.83%
GH price to book ratio is higher than 0.83% of companies in Healthcare sector

PS Ratio

PS ratio

8.07
GH price to sales ratio is 8.07

PS ratio Sector rank

74.42%
GH price to sales ratio is higher than 74.42% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.77B
GH enterprise value is $6.77 billion

Enterprise value Sector rank

90.08%
GH enterprise value is higher than 90.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-17.36
GH EV/EBITDA is -17.36

EV/EBITDA Sector rank

7.12%
GH EV/EBITDA is higher than 7.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.68
GH annual current ratio is 4.68

Quick ratio

4.36
GH annual quick ratio is 4.36

Leverage

Debt to equity

-8.18
GH annual debt to equity ratio is -8.18

Interest coverage ratio

-167.57
GH annual interest coverage ratio is -167.57

Risk & Stability

Piotroski F-Score

4
GH piotroski f-score is 4

Altman Z-Score

-0.02
GH altman z-score is -0.02

Analyst ratings

Recent major analysts updates

Apr 10, 25 Mizuho
Outperform
Apr 10, 25 Barclays
Overweight
Mar 26, 25 Stephens & Co.
Overweight
Mar 6, 25 Morgan Stanley
Overweight
Feb 26, 25 Piper Sandler
Overweight
Feb 24, 25 Scotiabank
Sector Outperform
Feb 24, 25 Guggenheim
Buy
Feb 24, 25 Canaccord Genuity
Buy
Feb 21, 25 Stifel
Buy
Feb 21, 25 Raymond James
Outperform

Institutional Ownership

Similar stocks

BRKR logo
Bruker (BRKR)
STVN logo
Stevanato Group SpA (STVN)
SRPT logo
Sarepta Therapeutics (SRPT)
CRL logo
Charles River Laboratories International (CRL)
TFX logo
Teleflex Incorporated (TFX)
Telix Pharmaceuticals Limited (TLX)
LEGN logo
Legend Biotech (LEGN)
BPMC logo
Blueprint Medicines (BPMC)
MMSI logo
Merit Medical Systems (MMSI)
  • What is the ticker symbol for Guardant Health?
  • Does Guardant Health pay dividends?
  • What sector is Guardant Health in?
  • What industry is Guardant Health in?
  • What country is Guardant Health based in?
  • When did Guardant Health go public?
  • Is Guardant Health in the S&P 500?
  • Is Guardant Health in the NASDAQ 100?
  • Is Guardant Health in the Dow Jones?
  • When was Guardant Health's last earnings report?
  • When does Guardant Health report earnings?
  • Should I buy Guardant Health stock now?

What is the ticker symbol for Guardant Health?

The ticker symbol for Guardant Health is NASDAQ:GH

Does Guardant Health pay dividends?

No, Guardant Health does not pay dividends

What sector is Guardant Health in?

Guardant Health is in the Healthcare sector

What industry is Guardant Health in?

Guardant Health is in the Diagnostics & Research industry

What country is Guardant Health based in?

Guardant Health is headquartered in United States

When did Guardant Health go public?

Guardant Health's initial public offering (IPO) was on October 4, 2018

Is Guardant Health in the S&P 500?

No, Guardant Health is not included in the S&P 500 index

Is Guardant Health in the NASDAQ 100?

No, Guardant Health is not included in the NASDAQ 100 index

Is Guardant Health in the Dow Jones?

No, Guardant Health is not included in the Dow Jones index

When was Guardant Health's last earnings report?

Guardant Health's most recent earnings report was on Feb 20, 2025

When does Guardant Health report earnings?

The next expected earnings date for Guardant Health is Apr 30, 2025

Should I buy Guardant Health stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page